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FIGURE 1. Chylous pleural fluid sample.
FIGURE 2. Thoracic duct ligation at video-assisted thoracic surgery.
Case ReportsSymptoms will include expectoration of milky-white,
foul-tasting sputum. However, the degree of production
will be variable and not necessarily postprandial or linked
with fatty food consumption. Lymphangiograms can aid
in the diagnosis, although this is dependent on the speed
of accumulation of the chyle leak. Where it is not available,
radionuclide lymphoscintigraphy, normally reserved for
imaging of malignant disease or lymphedema of the ex-
tremities, also can be used to visualize abnormalities of
the thoracic duct.4
CONCLUSIONS
Iatrogenic injury to the thoracic duct is a not an uncom-
mon consequence of thoracic cavity surgery. We present
a case of such an injury after distal aortic arch repair, with
persistent chylothorax and chyloptysis as a consequence.From the Thoracic Surgery and Lung Transplantation Unit, University Hospital Reina
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The Journal of Thoracic and CaAlthough the preference of the original treating surgeon
was to attempt surgical correction via redo thoracotomy,
in this case right-assisted video-assisted thoracoscopy
duct ligation was used as a successful conclusive treatment
modality. Because video-assisted thoracic surgery has a rel-
atively low morbidity and cost, earlier use of this approach
is supported by the literature.5
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management of postoperative chylothorax. Ann Thorac Surg. 2001;71:448-51.Lung transplant in Jehovah’s Witness patientFrancisco Cerezo Madue~no, MD, Elisabet Arango Tomas, MD, and Angel Salvatierra Velazquez, MD,
Cordoba, SpainStudying transplant candidates can be difficult, especially if
the patient states that he or she cannot accept homologous
blood products, such as Jehovah’s Witnesses. This has
been discussed in the medical literature1; however, there
are only 2 documented cases of lung transplantation
(LT).2,3 We present the first right single LT for
emphysema-type chronic obstructive pulmonary disease
(COPD) in a man who is a Jehovah’s Witness.rdiovascular Surgery c Volume 145, Number 6 e65
FIGURE 1. Chart of postoperative follow-up of patient’s hematocrit.
TABLE 1. Comparison between our case and the 2 previously
published cases
Conte and Orens2
(1999)
Grande et al3
(2003)
Cerezo
Madue~no et al
(2013)
Age, y 48 38 56
Gender Female Female Male
Pathology IPF IPF COPD
Secondary
pulmonary
hypertension
Yes No No
Type of
transplant
Left single lung Left single lung Right single lung
Survival ? 14 mo (acute
rejection)
25 mo
IPF, Idiopathic pulmonary fibrosis; COPD, chronic obstructive pulmonary disease.
Case ReportsCLINICAL SUMMARY
A 56-year-old man with terminal emphysema-type
COPD was accepted as a right single LT candidate. The pa-
tient stated from the outset that he could not accept any kind
of blood product for religious reasons. His functional test
results were as follows: partial pressure of oxygen ¼ 62
mm Hg, partial pressure of carbon dioxide ¼ 68 mm Hg,
forced vital capacity¼ 2180 mL (51.1%), and forced expi-
ratory volume in 1 second ¼ 520 mL (16.4%). No steps
were taken to increase the hemoglobin pretransplant be-
cause transplantation is an unpredictable procedure and in-
traoperative bleeding risk for single LT for COPD is
comparable to that for pneumonectomy.
A right single LT was performed, with an ischemic time
of 340 minutes. No extracorporeal circulation was required,
and there were no intraoperative complications. Attention
was given at all times to hemostatic technique. No cell-
saver or antifibrinolytic drugs were used intraoperatively.
During surgery, we administered ascorbic acid 500 mg be-
fore reperfusion systematically with N-acetylcysteine and
methylprednisolone.
In the early intensive care unit (ICU) phase, the patient
had anemia. Aweekly dose of erythropoietin was adminis-
tered with vitamin C 1 g/24 hours for 13 days and iron(II)
lactate for 23 days to support the patient’s hematocrit post-
operatively (Figure 1). Postoperative functional test results
were as follows: partial pressure of oxygen ¼ 385 mm Hg,
partial pressure of carbon dioxide ¼ 47.4 mm Hg, and
oxygenation index ¼ 385. Respiratory physiotherapy was
instituted from the ICU, and the patient remained there for
13 days. The patient remained in the hospital 35 days. He
presented the following complications: an episode of acute
rejection and pneumonia. Immunosuppressive therapy con-
sisted of cyclosporine A, mycophenolate mofetil, and corti-
coids. Medical follow-up was instituted, and the patient had
no marrow suppression. At 18 months of follow-up, thee66 The Journal of Thoracic and Cardiovascular Surgpatient was asymptomatic, with a good quality of life and
performance status. The patient has since died, 25 months
after receiving the transplant, having developed obstructive
bronchial syndrome 7 months before death.
DISCUSSION
Jehovah’s Witnesses do not believe in accepting homolo-
gous blood or blood products. In transplant candidates who
are Jehovah’s Witnesses, a number of conflicting moral is-
sues arise, and we need to reflect and seek well-founded
and coherent solutions that can help us make decisions.
On the basis of the universal principles of our code of med-
ical ethics, we justify the intercultural and transcultural de-
cisions.4 Solutions to problems of a moral nature require
careful thought supported by professional experience.1 It
is morally unacceptable to put the life of a patient at risk
if there are conservative resources. Furthermore, the auton-
omy of a patient who accepts a transplant on the condition
that no blood will be administered if necessary should be re-
spected. Several authors have published their experience re-
garding the possibility of minimizing blood loss and
avoiding blood transfusions when studying issues related
to organ transplantation in patients who are Jehovah’s Wit-
nesses5; however, cases of LT are scarce2,3 (Table 1).
We believe that it is necessary to select the patients in such
cases. There is no clinical experience in double LT for Jeho-
vah’s Witnesses. Double LT increases blood loss and the
need for a blood transfusion. Single LT generally has fewer
intraoperative complications than double LT with fewer
transfusions and extracorporeal circulation. In addition,
our experience shows that pulmonary emphysema, which
is the most frequent reason for transplantation, is usually
the least problematic surgically and postoperative care is
usually better tolerated. Intraoperative bleeding risk for sin-
gle LTin a patientwithCOPD is comparable to that for pneu-
monectomy. In our case, the risk of anemia/hemorrhagewasery c June 2013
Case Reportsless than the risk of respiratory failure. Thus, single LT may
be chosen for cases with low bleeding risk, such as COPD.
However, some measures should be taken for double LT:
decrease the time on the waiting list (emergency code), in-
crease the pretransplant hemoglobin (erythropoietin), and
consider preoperative self-donation. Multiple transfusions
can be required given the marrow-suppressing effect of the
medications and anemia of chronic disease. These were
not present in our case, but they could be treated with
erythropoietin and pharmacologic efforts.
From the beginning of our LT program in October of
1993, we have performed approximately 400 LTs. In the
last 10 years, 70 LTs were for COPD, and the patients re-
mained in the ICU for 12 days and the hospital for 45
days. The described case was within normal ranges, and
these results may be due to Spain’s social and health
services system.From the Department of Cardiovascular Surgerya and the Department of Radiology,b
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The Journal of Thoracic and CaCONCLUSIONS
Our case showed that LT can be performed safely in
Jehovah’s Witnesses and offers a new perspective when de-
ciding whether to perform major surgery and at the same
time comply with the conditions that Jehovah’s Witnesses
follow, allowing for LT to be performed in patients who oth-
erwisewould have been excluded from the list of candidates.
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left internal carotid artery caused by paradoxical embolus through
a persistent foramen ovale in a 32-year-old womanBrigitte Gansera, MD,a Michael Bauer, MD,b Laura Gansera,a and Walter Eichinger, MD, PhD,a Munich,
GermanyIn 1877, Cohnheim1 was the first to report a case of par-
adoxical embolism. Zahn2 described the first patient in
which necropsy revealed a thrombus localized in the
foramen ovale. Cerebrovascular accidents caused by par-
adoxical embolism through a persistent foramen ovale
are rare, but have been described as a reason for them,
especially in young patients with no other risk factors.3
We describe, to our knowledge, a unique case of a 32-
year-old woman with pulmonary embolism and occlusion
of the left internal and external carotid arteries caused by
paradoxical embolism through a patent foramen ovale
(PFO).CLINICAL SUMMARY
A 32-year-old woman with clinical signs of right-side
hemiplegia, aphasia, and dyspnea was transferred urgently
from the stroke unit of another hospital to our department
of cardiac surgery. The day before, the patient experienced
an isolated, sudden occurrence of right-hand paresthesia
and dizziness. She also complained of left-side leg pain,
without other previous symptoms. Risk factors for deep
venous thrombosis were oral contraceptives, smoking, and
extreme obesity (body mass index, 50).
Computed tomography (CT)–angiography was per-
formed and sagittal sinus thrombosis was detected. Duplex
ultrasound of the extremities showed thrombosis of the right
and left femoral veins. Initially, the patient received a bolus
of 5000 IU heparin followed by continuous administration
of heparin (30,000 IU/24 hours). The next day the patient’s
neurologic symptoms worsened rapidly (right-side hemi-
plegia and aphasia) and were accompanied by dyspnea.
Additional duplex ultrasound and CT–angiography re-
vealed complete occlusion of the left internal carotid artery
(Figure 1); the vertebral arteries were normal. Transcranial
ultrasound showed collateralization via the communicating
artery from the right side to the left. At first, cerebral CT did
not show any pathologic results. With the suspicion ofrdiovascular Surgery c Volume 145, Number 6 e67
